The Journal of Experimental Medicine
VeriKine-HS Human IFN-Beta
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online 6 November 2006 doi:10.1084/jem.20060936
Rockefeller University Press, 0022-1007 $8.00
JEM, Volume 203, Number 12, 2603-2611
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 4373K)
Right arrow PPT slides of all figures
Right arrow Supplemental Material Index
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Das, G.
Right arrow Articles by Shi, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Das, G.
Right arrow Articles by Shi, Y.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
Medline Plus Health Information
*Autoimmune Diseases
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

ARTICLE

Pivotal roles of CD8+ T cells restricted by MHC class I–like molecules in autoimmune diseases

Gobardhan Das1,2, Jyoti Das1, Paul Eynott2, Yingyu Zhang1, Alfred L.M. Bothwell3, Luc Van Kaer4, and Yufang Shi1

1 Department of Molecular Genetics, Microbiology and Immunology, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, Piscataway, NJ 08854
2 Department of Internal Medicine, Sanofi-Aventis, Bridgewater, NJ 08807
3 Section of Immunobiology, Yale University School of Medicine, New Haven, CT 06520
4 Department of Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, TN 37232

CORRESPONDENCE Yufang Shi: shiyu{at}umdnj.edu OR Gobardhan Das: dasgo{at}umdnj.edu

Unlike T cells restricted by major histocompatibility complex (MHC) class Ia or class II molecules, T cells restricted by MHC class I–like molecules demonstrate properties of both innate and adaptive immunity and are therefore considered innate-like lymphocytes (ILLs). ILLs are believed to have immunoregulatory functions, but their roles in autoimmunity and defense against infections remain elusive. To study the properties of ILLs, we generated mice expressing only MHC class I–like molecules by crossing CIITA–/– with Kb–/–Db–/– mice. Surprisingly, these mice developed a lymphoproliferative syndrome and autoimmunity, most notably inflammatory bowel disease (IBD) and insulitis. The CD8+ ILLs in these mice exhibit a constitutively activated phenotype, and depletion of these cells abolished the autoimmune disorders. In addition, adoptive transfer of CD8+ ILLs from Kb–/–Db–/–CIITA–/– mice to Rag-1–/–pfn–/– mice also resulted in IBD and insulitis. These findings provide direct evidence that CD8+ ILLs are sufficient to initiate and mediate autoimmune diseases.


Abbreviations used: CFSE, carboxyfluorescein diacetate succinimidyl ester; H&E, hematoxylin and eosin; HLA, histocompatibility leukocyte antigen; IBD, inflammatory bowel disease; ILL, innate-like lymphocyte; Tg, transgenic.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS